KromaTiD receives $2M of growth investment from BroadOak Capital Partners
LONGMONT -- KromaTiD announced BroadOak Capital Partners made a $2M investment in the company. KromaTiD said its sales and operations are rapidly accelerating, driven by growing market... Read More
Thursday April 29, 2021
KromaTiD announces addition of James Chomas to board of directors
LONGMONT -- KromaTiD announced Colorado biomedical entrepreneur James Chomas has joined the company's board of directors. Chomas has a track record of developing innovative healthcare... Read More
Friday February 12, 2021
KromaTiD announces appointment of Vic Myer to board of directors
LONGMONT -- KromaTiD, Inc. announced the appointment of Vic Myer to its board of directors. Myer joins KromaTiD's board with extensive experience in technology, RD and pharmaceutical company... Read More
Wednesday September 23, 2020
KromaTiD awarded Direct to Phase II SBIR grant by the National Human Genome Research Institute
LONGMONT -- KromaTiD, Inc. today announced it has been awarded a Direct to Phase II SBIR grant by the National Human Genome Research Institute. The award supports development of a structural... Read More
Monday August 24, 2020
KromaTiD announces launch of dGH In-Site
LONGMONT -- KromaTiD, Inc. announced the launch of its new productdGH In-Site, a single-cell, high resolution, genome-wide DNA insert tracking assay. dGH In-Site enables researchers to directly... Read More
Wednesday June 10, 2020
KromaTiD appoints Christopher Tompkins new company chief executive
LONGMONT -- KromaTiD, Inc. announced the appointment of Christopher Tompkins as CEO. Tompkins, who joined the company in 2010, most recently served as president, GM and chief technology... Read More
Wednesday June 26, 2019
KromaTiD receives $900K in funding from Human Genome Research Institute
FORT COLLINS-- KromaTiD, Inc . announced that after successfully meeting Phase 1 grant milestones, the company has been awarded Phase 2 funding from a Fast Track Small Business Innovation... Read More
Wednesday April 24, 2019
KromaTiD announces opening of new corporate headquarters in Longmont
LONGMONT -- KromaTiD, Inc. today announced the opening of the companys new corporate headquarters inColorado'sBoulder Countybiotech hub. The new facility includes corporate offices as well... Read More
Thursday March 28, 2019
IN Sponsors
Browse
Entrepreneurial by Nature
